The second-largest digital asset treasury increased its buying pace, while Strategy sold a chunk of its bitcoin holdings.
Silevertinib, Black Diamond Therapeutics' lead asset, showed strong Phase 2 results with 60% ORR and 86% CNS ORR. Read why ...
Gadget Review on MSN
16 AI trading tools that beat 99% of traders
16 AI trading tools transform raw market data into actionable strategies, from Claude-generated Pine Script to real-time news ...
Using AI and Australia's supercomputing infrastructure, researchers mapped 94 million craters on Mars, transforming planetary ...
NVIDIA’s fundamentals have never looked stronger, yet its stock is limping through 2026. NVIDIA (NASDAQ:NVDA) is up just 3.2% ...
Allegro MicroSystems, Inc. outlook: auto content growth, 800-VDC data centers, and robotics upside—plus a stronger balance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results